Combined renin-angiotensin system blockade and dietary sodium restriction impairs cardiomyocyte contractility

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 4, Issue 4, 2003, Pages 213-219

  Trongtorsak, Petcharat ^a,b   Morgan, Trefor O ^a   Delbridge, Lea M D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BURAPHA UNIVERSITY   (Thailand)

Author keywords

Angiotensin II; Angiotensin type 1 receptor antagonism; Angiotensin converting enzyme inhibition; Cardiomyocyte; Contraction; Dietary sodium; Inotropy

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; LOSARTAN; PERINDOPRIL; RENIN; SODIUM;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BODY GROWTH; CELL ISOLATION; CELL SIZE; CONTROLLED STUDY; GROWTH INHIBITION; HEART DISEASE; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HIGH SODIUM INTAKE; INOTROPISM; MUSCLE ATROPHY; NONHUMAN; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM INTAKE; SODIUM RESTRICTION;

EID: 0347519329     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2003.035     Document Type: Article

References (39)

1. Kim S, Iwao H. Molecular and cellular mechanism of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 2000;52:11-34.
2. Lui YH, Yang X-P, Sharo VG et al. Effects of angiotensin-converting enzyme inhibitors and angiotensin type 1 receptor antagonists in rats with heart failure. J Clin Invest 1997; 99:1926-35.
3. Azizi M, Linhart A, Alexander J et al. Pilot study of combined blockade of the renin-angiotensin system in essential hypertension patients. J Hypertens 2000;18:1139-47.
4. Kim S, Zhan Y, Izumi Y, Iwao H. Cardiovascular effects of combination of perindopril, candesartan, and amlodipine in hypertensive rats. Hypertension 2000;35:769-74.
5. Ohta T, Hasebe N, Tsuji S et al. Effects of angiotensin converting enzyme inhibitor and angiotensin II type 1 receptor blocker on cardiac dysfunction induced by isoproterenol in dogs. J Cardiovasc Pharmacol 2001;38(suppl 1):S63-S67.
6. Easthope SE, Jarvis B. Candesartan cilexetil: An update of its use in essential hypertension. Drugs 2002;62:1253-87.
7. van den Meiracker AH, Man in't Veld AJ, Admiraal PJJ, Ritsema van Eck HJ, Boomsma F, Derkx FHM. Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response? J Hypertens 1992;10:803-12.
8. Azizi M, Guyene T-T, Chatellier G, Wargon M, Menard J. Additive effect of losartan and enalapril on blood pressure and plasma active renin. Hypertension 1997;29:634-40.
9. Menard J, Campbell DJ, Azizi M, Gonzales M-F. Synergistic effects of ACE inhibition and angiotensin II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats. Circulation 1997;96:3072-8.
10. Dostal DE, Baker KM. The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function? Circ Res 1999;85:643-50.
11. Kawai H, Stevens SY, Liang CS. Renin-angiotensin system inhibition on noradrenergic nerve terminal function in pacing-induced heart failure. Am J Physiol 2000;279:H3012-H3019.
12. He FJ, Markandu ND, Sagnella GA, MacGregor GA. Importance of the renin system in determining blood pressure fall with salt restriction in black and white hypertensives. Hypertension 1998;32:820-4.
13. Cholewa BC, Mattson DL. Role of the renin-angiotensin system during alterations of sodium intake in conscious mice. Am J Physiol 2001;281:R987-R993.
14. Morgan TO, Aubert J-F. Wang Q. Sodium, angiotensin II, blood pressure, and cardiac hypertrophy. Kidney Int 1998; 54(suppl 67):213-15.
15. Teravainen T-L, Mervaala EMA, Laakso J, Paakkari I, Vapaatalo H, Karppanen H. Influence of age on cardiovascular effects of increased dietary sodium and angiotensin-converting enzyme inhibition in normotensive Wistar rats. J Pharm Pharmacol 1997;49:912-18.
16. Herlitz H, Dahlof B, Jonsson O, Friberg P. Relationship between salt and blood pressure in hypertensive patients on chronic ACE-inhibition. Blood Pressure 1998;7:47-52.
17. Griffiths CD, Morgan TO, Belbridge LM. Effects of combined administration of ACE inhibitor and angiotensin II receptor antagonist are prevented by a high NaCl intake. J Hypertens 2001;19:2087-95.
18. Abro E, Griffiths CD, Morgan TO, Delbridge LM. Regression of cardiac hypertrophy in the SHR by combined renin-angiotensin system blockade and dietary sodium restriction. JRAAS 2001;2:148-53.
19. Delbridge LM, Morgan TO, Harris PJ. Effects of endothelin-1 on the contractility of cardiomyocytes from the spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 1995; 22:755-62.
20. Di Nicolantonio R, Silvapulle MJ, Spargo S, Morgan TO. High salt diet decreases longevity in the spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 1988;15:357-9.
21. Delbridge LM, Harris PJ, Morgan TO. Characterization of single heart cells contractility by rapid imaging. Clin Exp Pharmacol Physiol 1989;16:179-84.
22. Delbridge LM, Harris PJ, Pringle JT, Dally LJ, Morgan TO. A superfusion bath for single-cell recording with high-precision optical depth control, temperature regulation, and rapid solution switching. Eur J Physiol 1990;416:94-7.
23. Harris PJ, Stewart D, Cullinan MC, Delbridge LM, Dally L, Grinwald P. Rapid measurement of isolated cardiac muscle cell length using a line-scan camera. IEEE Trans Biomed Eng 1987;34:463-7.
24. Navis G, de Jong PE, Donker AJM, van der Hem K, de Zeeuw D. Diuretic effects of angiotensin-converting enzyme inhibition: comparison of low and liberal sodium diet in hypertensive patients. J Cardiovasc Pharmacol 1987;9:743-8.
25. Muller DN, Fischi W, Clozel J et al. Local angiotensin II generation in the rat heart role of renin uptake. Circ Res 1998;82:13-20.
26. Chen LY, He Q, Jiang LQ, Cul CJ, Xu L, Liu LS. Transgenic study of the function of chymase in heart remodeling. J Hypertens 2002;20:2047-55.
27. Xu J, Carretero OA, Lui YH et al. Role of AT2 receptors in the cardioprotective effect of AT1 antagonists in mice. Hypertension 2002;40:244-50.
28. Horiuchi M, Akishita M, Dzau V. Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension 1999;33:613-21.
29. Lee S, Kramer CM, Mankad S, Yoo SE, Sandberg K. Combined angiotensin converting enzyme inhibition and angiotensin AT1 receptor blockade up-regulates myocardial AT2 receptors in remodeled myocardium post-infarction. Cardiovasc Res 2001;51:131-9.
30. Frohlich ED, Chien Y, Sesoko S, Pegram BL. Relationship between dietary sodium intake, hemodynamics, and cardiac mass in SHR and WKY rats. Am J Physiol 1993;264:R30-R34.
31. Gu J-W, Anand V, Shek EW et al. Sodium induces hypertrophy of cultured myocardial myoblasts and vascular smooth muscle cells. Hypertension 1998;31:1083-7.
32. Harmsen E Leenen FHH. Dietary sodium induced cardiac hypertrophy. Can J Physiol Pharmacol 1992;70:580-6.
33. Ito K, Nakayama M, Hasan F, Yan X, Schneider MD, Lorell BH. Contractile reverse and calcium regulation are depressed in myocytes from chronically unloaded hearts. Circulation 2003;107:1176-82.
34. Thompson EW, Marino TA, Uboh CE, Kent RL, Cooper IVG. Atrophy reversal and cardiocyte redifferentiation in unloaded cat myocardium. Circ Res 1984;54:367-77.
35. 2+ handling in normal and hypertrophied rat myocardium. J Mol Cell Cardiol 1998;30:2507-18.
36. Kobayashi T, Hamada M, Okayama H, Shigematsu Y, Sumimoto T, Hiwada K. Contractile properties of left ventricular myocytes isolated from spontaneously hypertensive rats: effect of angiotensin II. J Hypertens 1995;13:1803-07.
37. Cheng CP, Suzuki M, Ohte N, Wang ZM, Little WC. Altered ventricular myocyte response to angiotensin II in pacing-induced heart failure. Circ Res 1996;78:880-92.
38. De Mello W. Intracellular angiotensin II regulates the inward calcium current in cardiac myocytes. Hypertension 1998;32:976-82.
39. Schuijt MP, Danser AH. Cardiac angiotensin II: an intracrine hormone? Am J Hypertens 2002;15:1109-16.